CurrentCardio coverage · page 10 of 11
JACC: Cardiovascular Interventions
Latest from JACC: Cardiovascular Interventions
JACC Cardiovasc Interv
Device-Related Thrombus After Left Atrial Appendage Occlusion: Clinical Impact, Predictors, Classification, and Management
Research articleArrhythmias & EP
JACC Cardiovasc Interv
JACC Cardiovasc Interv
JACC Cardiovasc Interv
1-Year Outcomes Following Transfemoral Transseptal Transcatheter Mitral Valve Replacement: The HighLife TSMVR Feasibility Study
Cohort studyValvular & structural
JACC Cardiovasc Interv
Applying the TRILUMINATE Eligibility Criteria to Real-World Patients Receiving Tricuspid Valve Transcatheter Edge-to-Edge Repair
Cohort studyValvular & structural
JACC Cardiovasc Interv
JACC Cardiovasc Interv
DAPT Is Comparable to OAC Following LAAC With WATCHMAN FLX: A National Registry Analysis
Cohort studyArrhythmias & EP
JACC Cardiovasc Interv
1-Year Outcomes From the CLASP IID Randomized Trial for Degenerative Mitral Regurgitation
Randomised controlled trialValvular & structural
JACC Cardiovasc Interv
1-Year Outcomes With Fourth-Generation Mitral Valve Transcatheter Edge-to-Edge Repair From the EXPAND G4 Study
Cohort studyValvular & structural
JACC Cardiovasc Interv
Balloon- vs Self-Expanding Transcatheter Valves for Failed Small Surgical Aortic Bioprostheses: 1-Year Results of the LYTEN Trial
Randomised controlled trialValvular & structural
JACC Cardiovasc Interv
Coronary Physiology Guidance vs Conventional Angiography for Optimization of Percutaneous Coronary Intervention: The AQVA-II Trial
Randomised controlled trialCoronary & ACS
JACC Cardiovasc Interv
Dyspnea-Related Ticagrelor Discontinuation After Percutaneous Coronary Intervention
Secondary analysisCoronary & ACS
JACC Cardiovasc Interv
JACC Cardiovasc Interv
A Prospective Randomized Trial Comparing Sirolimus-Coated Balloon With Paclitaxel-Coated Balloon in De Novo Small Vessels
Randomised controlled trialCoronary & ACS
JACC Cardiovasc Interv
JACC Cardiovasc Interv
Efficacy and Safety of Anticoagulation, Catheter-Directed Thrombolysis, or Systemic Thrombolysis in Acute Pulmonary Embolism
Meta-analysisPulmonary vascular & VTE
JACC Cardiovasc Interv
JACC Cardiovasc Interv
QFR Assessment and Prognosis After Nonculprit PCI in Patients With Acute Myocardial Infarction
Secondary analysisCoronary & ACS
JACC Cardiovasc Interv
Impact of Post-PCI FFR Stratified by Coronary Artery
Meta-analysisCoronary & ACS
JACC Cardiovasc Interv
Everolimus-Eluting Stents or Bypass Surgery for Multivessel Disease in Diabetics: The BEST Extended Follow-Up Study
Secondary analysisCoronary & ACS
JACC Cardiovasc Interv
JACC Cardiovasc Interv
Diagnosis, Classification, and Management Strategies for Mitral Annular Calcification: A Heart Valve Collaboratory Position Statement
Guideline or statementValvular & structural
JACC Cardiovasc Interv
Implications of a Race Term in GFR Estimates Used to Predict AKI After Coronary Intervention
Cohort studyCoronary & ACS
JACC Cardiovasc Interv
Cardiac Death After Transcatheter Aortic Valve Replacement With Contemporary Devices
Cohort studyValvular & structural
JACC Cardiovasc Interv
5-Year Prospective Evaluation of Mitral Valve-in-Valve, Valve-in-Ring, and Valve-in-MAC Outcomes: MITRAL Trial Final Results
Cohort studyValvular & structural
JACC Cardiovasc Interv
Outcomes of Transcatheter Aortic Valve Replacement in Asymptomatic or Minimally Symptomatic Aortic Stenosis
Cohort studyValvular & structural
JACC Cardiovasc Interv
Late Bleeding Events in Patients Undergoing Percutaneous Coronary Intervention in the Workup Pre-TAVR
Cohort studyCoronary & ACS
JACC Cardiovasc Interv
CTO and Bifurcation Lesions: An Expert Consensus From the European Bifurcation Club and EuroCTO Club
Guideline or statementAortic & peripheral
JACC Cardiovasc Interv
Outcomes Based on Angiographic vs Functional Significance of Complex 3-Vessel Coronary Disease: FAME 3 Trial
Secondary analysisCoronary & ACS
JACC Cardiovasc Interv
Direct Comparison of Rotational vs Orbital Atherectomy for Calcified Lesions Guided by Optical Coherence Tomography
Randomised controlled trialCoronary & ACS
JACC Cardiovasc Interv
Incidence, Predictors, and Prognostic Impact of Bleeding Events After TAVR According to VARC-3 Criteria
Cohort studyValvular & structural
JACC Cardiovasc Interv
Transcatheter Aortic Valve Replacement for Isolated Aortic Regurgitation Using a New Self-Expanding TAVR System
Cohort studyValvular & structural
JACC Cardiovasc Interv
Sex Differences in Fractional Flow Reserve– or Intravascular Ultrasound–Guided Percutaneous Coronary Intervention
Secondary analysisCoronary & ACS
JACC Cardiovasc Interv
Restoration of Life Expectancy After Transcatheter Edge-to-Edge Mitral Valve Repair
Cohort studyValvular & structural
JACC Cardiovasc Interv
MIRACLE2 Score Compared With Downtime and Current Selection Criterion for Invasive Cardiovascular Therapies After OHCA
Cohort studyAcute care & resuscitation
JACC Cardiovasc Interv
Stressed Blood Volume in Severe Tricuspid Regurgitation: Implications for Transcatheter Treatment
Cohort studyValvular & structural
JACC Cardiovasc Interv
Switching From Cangrelor to Prasugrel in Patients Undergoing Percutaneous Coronary Intervention: The Switching Antiplatelet-6 (SWAP-6) Study
Randomised controlled trialCoronary & ACS
JACC Cardiovasc Interv
3-Year Outcomes From the Amplatzer Amulet Left Atrial Appendage Occluder Randomized Controlled Trial (Amulet IDE)
Randomised controlled trialArrhythmias & EP
JACC Cardiovasc Interv
JACC Cardiovasc Interv